INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2012

Higher dietary lutein and zeaxanthin intake was linked to a lower risk of late and neovascular AMD, but not early AMD.

A systematic review and meta-analysis of six longitudinal cohort studies examined the relationship between dietary lutein and zeaxanthin intake and age-related macular degeneration (AMD) risk. Comparing the highest with the lowest intake categories, the pooled relative risk was 0.96 (95% CI 0.78, 1.17) for early AMD. Intake was significantly linked to a reduced risk of late AMD (RR 0.74; 95% CI 0.57, 0.97) and neovascular AMD (RR 0.68; 95% CI 0.51, 0.92).

Shows an association, not proof of cause and effect.

Study type
Systematic review and meta-analysis of cohort studies
Who was studied
Participants in six longitudinal cohort studies identified up to April 2010
What was measured
Risk of early AMD, late AMD, and neovascular AMD

THE PAPER

Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.

Ma L, Dou HL, Wu YQ, Huang YM, Huang YB, Xu XR, Zou ZY, Lin XM. Br J Nutr, 2012.

PubMed 21899805 ↗DOI 10.1017/s0007114511004260 ↗

Healthy aging & longevityOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.